PeriGen, Inc.

Founded in 1995 and based in New Jersey, US, PeriGen, Inc. provides risk management solutions and consulting services in the United States. Eyal Ephrat is the founder of the company. PeriGen Inc.

was formerly known as E&C Medical Intelligence, Inc. In September 2016, the firm raised an undisclosed amount of venture funding led by Ambina Partners including Galen Partners and Trident Capital, and in April 2021, Halma acquired PeriGen. The company's PeriWatch Vigilance® is an automated early warning system and clinical decision support tool for obstetrics, designed to enhance clinical efficiency, timely intervention, and standardization of care. It adds an artificial intelligence-based approach to patient safety initiatives and other analytical techniques, it continuously analyzes maternal vital signs, fetal heart rate, contractions, and labor progression.

The firm's PeriWatch Surveillance™ provides fetal surveillance and documentation, it includes the features that bedside clinicians, nurse managers, and physicians prefer for documenting and sharing information vital for patient care. PeriGen solutions can be used to help achieve a telehealth initiative at your facility. PeriGen can provide remote perinatal telemonitoring to enable nurses at larger urban/suburban hospitals to monitor mothers and babies across multiple facilities from a central monitoring location. Its clients include multi-hospital systems, academic institutions, and small community-based hospitals in North America.